Pradžia › LOPSL
LOPSL klinikiniai tyrimai JAV ieško dalyvių
98 tyrimai dėl LOPSL ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Philadelphia, PA23 tyrimai
- Miami, FL18 tyrimai
- Birmingham, AL17 tyrimai
- Boston, MA17 tyrimai
- Houston, TX15 tyrimai
- Orlando, FL15 tyrimai
- Baltimore, MD14 tyrimai
- Chicago, IL14 tyrimai
- Dallas, TX12 tyrimai
- Pittsburgh, PA12 tyrimai
- New York City, NY11 tyrimai
- Ann Arbor, MI10 tyrimai
- Winston-Salem, NC9 tyrimai
- Detroit, MI9 tyrimai
- Los Angeles, CA9 tyrimai
- Phoenix, AZ9 tyrimai
- Kansas City, KS9 tyrimai
- Charlotte, NC9 tyrimai
- Hialeah, FL8 tyrimai
- Newport Beach, CA8 tyrimai
- Columbus, OH8 tyrimai
- Cleveland, OH8 tyrimai
- Nashville, TN7 tyrimai
- Tampa, FL7 tyrimai
- Durham, NC7 tyrimai
- Kendall, FL7 tyrimai
- Denver, CO7 tyrimai
- Milwaukee, WI7 tyrimai
- Farmington Hills, MI6 tyrimai
- Jacksonville, FL6 tyrimai
- West Palm Beach, FL6 tyrimai
- Indianapolis, IN6 tyrimai
- Aurora, CO6 tyrimai
- Las Vegas, NV5 tyrimai
- St. Louis, MO5 tyrimai
- Shreveport, LA5 tyrimai
- El Paso, TX5 tyrimai
- Rapid City, SD5 tyrimai
- Baton Rouge, LA5 tyrimai
- Spartanburg, SC5 tyrimai
Pagal valstiją
- Aidahas4 tyrimai
- Ajova6 tyrimai
- Alabama21 tyrimas
- Arizona17 tyrimai
- Džordžija12 tyrimai
- Florida28 tyrimai
- Ilinoisas19 tyrimai
- Indianas10 tyrimai
- Kalifornija26 tyrimai
- Kanzasas12 tyrimai
- Kentukis5 tyrimai
- Koloradas15 tyrimai
- Konektikutas3 tyrimai
- Luiziana9 tyrimai
- Masčusetsas25 tyrimai
- Menas3 tyrimai
- Merilendas16 tyrimai
- Minesota11 tyrimai
- Misisipė3 tyrimai
- Misūris7 tyrimai
- Mičiganas22 tyrimai
- Montana3 tyrimai
- Nebraska5 tyrimai
- Nevada8 tyrimai
- New Jersey7 tyrimai
- New York19 tyrimai
- North Carolina22 tyrimai
- Ohio17 tyrimai
- Oklahoma8 tyrimai
- Oregon6 tyrimai
- Pennsylvania33 tyrimai
- South Carolina14 tyrimai
- South Dakota6 tyrimai
- Tennessee14 tyrimai
- Texas25 tyrimai
- Utah6 tyrimai
- Vermont5 tyrimai
- Virginia12 tyrimai
- Washington6 tyrimai
- West Virginia5 tyrimai
- Wisconsin8 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06283966Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
Renkami dalyviai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07072039Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07190222WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07558265To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Renkami dalyviai2 fazė
Amžius nuo 40 iki 85 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07684820Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
Renkami dalyviai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT05934565A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
Renkami dalyviai2 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07725939A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07780656: Vascular Function in Health and Disease
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT02966665A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Renkami dalyviai2 fazė
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Renkami dalyviai4 fazė
Amžius nuo 40 iki 85 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07053423A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Renkami dalyviai
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-17 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Renkami dalyviai2 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07646587Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
Renkami dalyviai4 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT07816835A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT06603246COPD Exacerbation Follow Up
Renkami dalyviaiStebimasis tyrimas
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT07118306The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
Renkami dalyviaiStebimasis tyrimas
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Renkami dalyviai2/3 fazė
Amžius nuo 35 iki 80 · Visoms lytims · Atnaujinta 2026-08-31 · NCT07363694Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.